NAAG Endorses Bankruptcy Venue Reform Act of 2021

November 9, 2021

We support H.R. 4193, and S. 2827, the Bankruptcy Venue Reform Act of 2021.

Read More →

NAAG Supports Senate Hearings on Social Media and Mental Health

October 5, 2021

As enforcers of our jurisdictions’ consumer protection laws, we find it deeply troubling that Facebook and other social media platforms seek to increase user engagement by conscripting our nation’s youth despite known harms to children and adolescents.

Read More →

Attorneys General Urge FCC to Accelerate Deadline for STIR/SHAKEN Adoption

August 9, 2021

The National Association of Attorneys General (NAAG) today urged the Federal Communications Commission (FCC) to fight back against the scourge of illegal robocalls by moving up the deadline for smaller telephone companies to implement caller ID technology. Under the TRACED Act, which became law in 2019, phone companies are required to implement STIR/SHAKEN technology on…

Read More →

Colorado et al. v. Google, No. 1:30-cv-03715 (D.D.C. Dec. 17, 2020)

July 12, 2021

Thirty-eight states sued Google, alleging that Google illegally maintains its monopoly power over general search engines and related general search advertising markets through a series of anticompetitive contracts and conduct, hurting both consumers and advertisers. Consumers are denied the benefits of competition, including the possibility of higher quality services and better privacy protections. Advertisers are…

Read More →

NAAG Submits Comment Letter on Beneficial Ownership Regulations

May 6, 2021

Our comments are consistent with the sense of Congress, which requires that regulations “to the greatest extent practicable… collect information in a form and manner that is reasonably designed to generate a database that is highly useful to… law enforcement agencies…” NDAA § 6402(8)(C).

Read More →

Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)

January 25, 2021

Eighteen states reached a settlement with Endo Pharmaceuticals Inc. under which Endo paid $2.3 million to settle allegations it entered into a reverse-payment agreement to obstruct generic competition to Lidoderm, a pain relief patch frequently used to treat shingles. According to the complaint, Endo had an agreement with Watson Laboratories Inc. ensuring Endo would not face…

Read More →

Attorneys General Urge Senate to Pass Law to Fight Shell Companies

October 26, 2020

As our States’ chief legal officers, we are concerned about the use of American financial institutions for money laundering by terrorist groups and other criminal enterprises.

Read More →

NAAG Endorses Stopping Overdoses of Fentanyl Analogues (SOFA) Act

October 22, 2020

States and localities are on the front line of this crisis and are a large part of winning the battle from both a law enforcement and public health perspective.

Read More →

New York et al. v. Deutsche Telekom AG et al., No. 1:19-cv-5434 (S.D.N.Y.)

October 9, 2020

States challenged merger of T-Mobile and Sprint, the third and fourth-largest mobile telecommunications providers in the U.S., alleging that shrinking the national wireless carrier pool down from four to three providers would decrease competition and create higher prices for consumers. The US Department of Justice and seven states entered into a settlement with the parties…

Read More →

California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)

October 9, 2020

Plaintiff states alleged that defendant, the producer of Lidoderm (pain medication), paid or incentivized generic drug makers to delay entry into market to protect its monopoly on Lidoderm. (“pay for delay”) The settlement agreement, which expires in twenty years, prohibits Teikoku from entering into agreements that restrict generic drug manufacturers from researching, manufacturing, marketing, or selling products for a period of time and requires Teikoku to cooperate in an ongoing investigation into similarly anticompetitive conduct by other drug manufacturers, among other things.

Read More →